Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149680 Kinase inhibitors
06/14/2012US20120149679 Sulfonamide Derivatives
06/14/2012US20120149678 Organonitro Compounds for Use in Treating Non-Hodgkin's Lymphoma and Leukemia, and Methods Relating Thereto
06/14/2012US20120149677 Ether benzotriazole derivatives
06/14/2012US20120149676 Novel compounds
06/14/2012US20120149675 1,2,3-triazole-imidazolecompounds
06/14/2012US20120149674 Diaryl Substituted Alkanes
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149672 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
06/14/2012US20120149671 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents
06/14/2012US20120149670 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
06/14/2012US20120149669 22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses
06/14/2012US20120149668 Glucocorticoid receptor alleles and uses thereof
06/14/2012US20120149667 Pharmaceutical compositions for treating ibd
06/14/2012US20120149666 Compositions and methods of treatment for inflammatory diseases
06/14/2012US20120149665 Combination therapy for treating proliferative diseases
06/14/2012US20120149664 Transdermal Composition of Phosphatidylcholine and Method for Producing Same
06/14/2012US20120149663 Boronic acid compositions and methods related to cancer
06/14/2012US20120149662 Heterocyclic Compounds as Janus Kinase Inhibitors
06/14/2012US20120149661 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
06/14/2012US20120149660 Novel n-substituted 5-hydroxypyrollindes as inhibitors of mdm2-p53 interactions
06/14/2012US20120149659 Compositions and methods for delivering an agent to a wound
06/14/2012US20120149658 Modified pectins, compositions and methods related thereto
06/14/2012US20120149657 2'-fluoro arabino nucleosides and use thereof
06/14/2012US20120149656 WATER SOLUTION OF 20(R) - GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF
06/14/2012US20120149655 Use of jasmonate to treat bladder dysfunction
06/14/2012US20120149653 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149647 Methods for Assessing the Efficacy of Gemcitabine or Ara-C Treatment of Cancer Using Human Antigen R Levels
06/14/2012US20120149639 Use of a dpp-iv inhibitor to reduce hypoglycemic events
06/14/2012US20120149637 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/14/2012US20120149630 End-modified poly(beta-amino esters) and uses thereof
06/14/2012US20120149057 Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
06/14/2012US20120148695 Pharmaceutical Compositions From Carapa Guianensis
06/14/2012US20120148693 Herbal Drug Composition for Cartilage Protection
06/14/2012US20120148690 Skin barrier function recovery accelerator
06/14/2012US20120148689 Film comprising active drugs
06/14/2012US20120148685 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
06/14/2012US20120148684 Methods useful in the treatment of bone resorption diseases
06/14/2012US20120148678 Sustained release of poorly water soluble active compounds
06/14/2012US20120148675 Testosterone undecanoate compositions
06/14/2012US20120148674 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/14/2012US20120148673 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
06/14/2012US20120148671 Gastric retained gabapentin dosage form
06/14/2012US20120148670 Sensitive polymer capsule and method of manufacturing the same
06/14/2012US20120148669 Method for preparing functionalized lipid capsules
06/14/2012US20120148667 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
06/14/2012US20120148665 Topical composition containing naproxen
06/14/2012US20120148664 Chemical modifications motifs for mirna inhibitors and mimetics
06/14/2012US20120148663 Lipophilic drug carrier
06/14/2012US20120148662 Formulation
06/14/2012US20120148661 High bioavailability oral picoplatin anti-cancer therapy
06/14/2012US20120148660 Conjugates of synthetic tlr agonists and uses therefor
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148656 Sheet-form preparation and method for producing the same
06/14/2012US20120148655 Multi-layered gradient vaginal ring
06/14/2012US20120148641 Methods of treatment of endobronchial infections
06/14/2012US20120148640 Pharmaceutical Composition Comprising Pimobendan
06/14/2012US20120148638 Steroid Solavates
06/14/2012US20120148637 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
06/14/2012US20120148636 Microparticles and method of making microparticles
06/14/2012US20120148635 Gallium formulation for the treatment and prevention of infectious diseases
06/14/2012US20120148634 Novel formulation of naproxen
06/14/2012US20120148631 Pegylated polyplexes for polynucleotide delivery
06/14/2012US20120148612 Grass peptides for vaccine
06/14/2012US20120148604 Trp inhibitors and uses thereof
06/14/2012US20120148603 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
06/14/2012US20120148602 Cancer Treatment With Endothelin Receptor Antagonists
06/14/2012US20120148595 Gaba-linked anthracycline-lipid conjugates
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148589 Human cancer-related gene, its encoded products and applications
06/14/2012US20120148584 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the threatment of early stage tumors
06/14/2012US20120148577 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
06/14/2012US20120148569 Picrorhiza kurroa extract for prevention, elimination and treatment of infection diseases
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148564 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
06/14/2012US20120148561 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets
06/14/2012US20120148560 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148547 Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120148531 Fused heterocyclic derivatives and methods of use
06/14/2012US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds
06/14/2012US20120148522 Biocompatible Polyelectrolyte Complexes and Methods of Use
06/14/2012US20120148521 Methods and Compositions for Controlled Release of Drugs
06/14/2012US20120148520 Organic Iodine Complex Durable Barrier With Antimicrobial Preparations
06/14/2012US20120148519 Ophthalmic lens
06/14/2012US20120148510 Compositions and Methods for Improving the Appearance of Facial Pores
06/14/2012US20120148509 Composition for alleviating ultraviolet irradiation-induced damage
06/14/2012US20120148504 Complex of garcinol, cyclodextrin and method thereof
06/14/2012US20120148502 Carbohydrate-Mediated Tumor Targeting
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/14/2012US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases
06/14/2012US20120148489 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012US20120148488 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012US20120145588 Method for improving compliance with a treatment regimen for treating or preventing osteoporosis
06/14/2012US20120145320 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
06/14/2012DE102010062544A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, pulmonary hypertension and vascular disease
1 ... 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 ... 7860